Portfolio (Quarterly)
Guide ↗
Rosalind Advisors, Inc.
· CIK 0001622627| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SVRA | SAVARA INC | Healthcare | 3,203,721.0 | $17.5M | 7.03% | -200K | -5.9% | $5.46 | -5.9% |
| 2 | HELP | CYBIN INC | Healthcare | 1,531,814.0 | $7.4M | 2.95% | -126K | -7.6% | $4.80 | -7.7% |
| 3 | CGON | CG ONCOLOGY INC | Healthcare | 100,000.0 | $6.8M | 2.72% | -200K | -66.7% | $67.68 | -8.7% |
| 4 | PROF | PROFOUND MEDICAL CORP | Healthcare | 828,118.0 | $5.4M | 2.16% | -241K | -22.5% | $6.48 | +4.5% |
| 5 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 250,401.0 | $4.9M | 1.97% | -200K | -44.4% | $19.56 | -13.1% |
| 6 | — | POLYPID LTD | — | 597,926.0 | $2.6M | 1.05% | -99K | -14.2% | $4.38 | — |
| 7 | — | TALPHERA INC | — | 3,353,916.0 | $2.5M | 1.01% | -225K | -6.3% | $0.75 | — |
| 8 | — | ONKURE THERAPEUTICS INC | — | 443,763.0 | $1.8M | 0.74% | -287K | -39.2% | $4.14 | — |
| 9 | — PUT | INVESCO QQQ TR | — | 250,000.0 | $1.1M | 0.42% | -200K | -44.4% | $4.21 | — |
| 10 | — PUT | SPDR S&P 500 ETF TR | — | 125,000.0 | $958K | 0.39% | -385K | -75.5% | $7.67 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%